Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status

15th July 2021 Uncategorised 0

At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772

More: Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
Source: News